Aclaris Therapeutics (8AT.F) Q1 2025 Earnings

Feb 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.97
-0.65
-0.33
-0.01

Details

Expected EPS
-0.2756589872
Actual EPS
-0.971216
Surprise EPS
-0.7
Surprise Percent
-252.33%

Description

⁨Aclaris Therapeutics⁩ (⁦8AT.F⁩) has reported earnings of ⁦-0.971216⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts